News – Page 693 – Endpoints News

Bristol Myers' Opdivo leads the pack with FDA approval for resected esophageal or GEJ cancer

4 years ago

Novartis, BeiGene's PD-(L)1 play takes home another win in late-stage data, adding some heft to its market potential

4 years ago

CFO transition on the horizon at BioNTech as Sierk Poetting concentrates on COO duties; Centessa rides a wave of new ...

4 years ago

Bluebird’s new gene therapy among three new EMA OKs ahead of FDA

4 years ago

Arie Belldegrun's vision for Ginkgo comes into view, as the now $15B company teams with Biogen on gene therapy

4 years ago

Takeda tees up priority review for storied CMV drug from its $62B Shire buyout

4 years ago

In tight next-gen pneumococcal vaccine race with Pfizer, Merck reads out topline pediatric data

4 years ago

Stinging from a proxy loss and hungry for cash, GlaxoSmithKline bails on equity stake in Innoviva for a tidy $392M

4 years ago

Eli Lilly sues HHS to halt any 340B-related monetary penalties

4 years ago

A new RNA startup looks to reimagine heart treatments, with eyes set on Entresto

4 years ago

FDA revises and expands draft guidance on adjusting for covariates in RCTs

4 years ago

Resilience has caught the eye of the Canadian government, which will invest $163M to boost mRNA production

4 years ago

After record-breaking demand for injectables, BD to expand in Spain with $200M Zaragoza plant

4 years ago

Novartis' Sandoz reshuffles antibiotic supply chain in EU as field faces a shortage of investment

4 years ago

#ASCO21: Watch out Bristol Myers, J&J is back at ASCO with some competitive BCMA CAR-T data

4 years ago

BioTheryX collects $92M in Series E round; WuXi Biologics ups its stake in an emerging ADC player

4 years ago

Covid-19 manufacturing report: Ireland will produce mRNA component for Pfizer's vaccine; Lonza recruits federal ...

4 years ago

HIV researcher David Ho has a new line of attack on SARS-CoV-2, and his fledgling startup is gunning for the clinic

4 years ago

House committee grills Emergent CEO Bob Kramer over J&J vaccine debacle, ill-timed stock sale

4 years ago

#ASCO21: Bristol Myers takes home the win in 1st late-stage study for LAG-3 pathway, setting up a US filing

4 years ago

FDA adcomm to review FibroGen’s chronic kidney disease drug in July

4 years ago

Be the spark? Roche’s Spark sues fellow gene therapy developer bluebird for ‘usurpation’ of trademark

4 years ago

Minority patients underrepresented in Covid-19 trials despite greater willingness to participate, report finds

4 years ago

Covid-19 roundup: Europe reserves 1.8 billion doses of Pfizer vaccines; Republicans slam Biden's TRIPS waiver support

4 years ago

First page Previous page 690 691 692693694 695 696 Next page Last page